Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Wedege

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Microbiology (Reading, England)|July 1, 1995
A linear B-cell epitope on the class 3 outer-membrane protein of Neisseria meningitidis recognized after vaccination with the Norwegian group B outer-membrane vesicle vaccineA A Delvig, E Wedege, D A Caugant, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2007
Functional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccinesE Wedege, K Bolstad, A Aase, et al.
Journal of Medical Microbiology|February 12, 2000
A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteersA K H Berstad, J Holst, L O Frøholm, et al.
Vaccine|March 4, 2000
Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccineA K Berstad, S R Andersen, R Dalseg, et al.
NIPH Annals|December 1, 1991
The Norwegian meningococcal serogroup B outer membrane vesicle vaccine protection trials: case tracing, meningococcal antigen detection and serological diagnosisE A Høiby, G Bjune, L O Frøholm, et al.
Vaccine|July 27, 1999
The infant rat model adapted to evaluate human sera for protective immunity to group B meningococciM Toropainen, H Käyhty, L Saarinen, et al.
Infection and Immunity|December 1, 1995
Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccineE Rosenqvist, E A Høiby, E Wedege, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 23, 2008
Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscriptsK Vainio, H H Samdal, G Anestad, et al.
Journal of Clinical Microbiology|February 1, 1994
Asymptomatic carriage of Neisseria meningitidis in a randomly sampled populationD A Caugant, E A Høiby, P Magnus, et al.
Clinical and Vaccine Immunology : CVI|February 20, 2009
Seroepidemiological study after a long-distance industrial outbreak of legionnaires' diseaseE Wedege, T Bergdal, K Bolstad, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Microbiology (Reading, England)|July 1, 1995
A linear B-cell epitope on the class 3 outer-membrane protein of Neisseria meningitidis recognized after vaccination with the Norwegian group B outer-membrane vesicle vaccineA A Delvig, E Wedege, D A Caugant, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2007
Functional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccinesE Wedege, K Bolstad, A Aase, et al.
Journal of Medical Microbiology|February 12, 2000
A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteersA K H Berstad, J Holst, L O Frøholm, et al.
Vaccine|March 4, 2000
Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccineA K Berstad, S R Andersen, R Dalseg, et al.
NIPH Annals|December 1, 1991
The Norwegian meningococcal serogroup B outer membrane vesicle vaccine protection trials: case tracing, meningococcal antigen detection and serological diagnosisE A Høiby, G Bjune, L O Frøholm, et al.
Vaccine|July 27, 1999
The infant rat model adapted to evaluate human sera for protective immunity to group B meningococciM Toropainen, H Käyhty, L Saarinen, et al.
Infection and Immunity|December 1, 1995
Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccineE Rosenqvist, E A Høiby, E Wedege, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 23, 2008
Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscriptsK Vainio, H H Samdal, G Anestad, et al.
Journal of Clinical Microbiology|February 1, 1994
Asymptomatic carriage of Neisseria meningitidis in a randomly sampled populationD A Caugant, E A Høiby, P Magnus, et al.
Clinical and Vaccine Immunology : CVI|February 20, 2009
Seroepidemiological study after a long-distance industrial outbreak of legionnaires' diseaseE Wedege, T Bergdal, K Bolstad, et al.
Pageof 6